RISANKIZUMAB

UNII:	90ZX3Q3FR7
Formula:
Preferred Substance Name:	RISANKIZUMAB

1612838-76-2
655066-01
ABBV-066
BI-655066
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 23 SUBUNIT P19) (HUMAN-MUS MUSCULUS HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL23A (INTERLEUKIN 23 SUBUNIT ALPHA, IL-23A, IL23 SUBUNIT P19, IL23P19)), HUMANIZED MONOCLONAL ANTIBODY
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN INTERLEUKIN-23 SUBUNIT ALPHA (IL-23-A, INTERLEUKIN-23 SUBUNIT P19, IL-23P19))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-449) (HUMANIZED VH (HOMO SAPIENS IGHV1-69*08 (79%) (IGHD)-IGHJ6*01 (91%)) (8.8.13) (1-120) -HOMO SAPIENS IGHG1*03 (CH2 L4>A(237), L5>A(238), CH3 K107>-(450)) (121-449)), (223-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-27*01 (80%) IGKJ2*02 (91%)) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (108'-214')) DIMER (229-229'':232-232'')-BISDISULFIDE
RISANKIZUMAB [INN]
RISANKIZUMAB [JAN]
RISANKIZUMAB [MI]
RISANKIZUMAB [USAN]
RISANKIZUMAB [WHO-DD]
RISANKIZUMAB RZAA [WHO-DD]
RISANKIZUMAB-RZAA
SKYRIZI

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RISANKIZUMAB

Synonyms and Mappings

Resources